Infantile fibrosarcoma with a novel RAF1 rearrangement: The contemporary challenge of reconciling classic morphology with novel molecular genetics

by Cheryl M. Coffin, Carol Beadling, Tanaya Neff, Christopher L. Corless, Jessica L. Davis
Published 2020-11-01

Case report: Novel PIK3CA and AXIN1 mutations in acinar cell carcinoma of the stomach arising from pancreatic heterotopia

by Brian T Brinkerhoff, Mandy VanSandt, Skye C Mayo, Carol Beadling, Christopher L Corless
Published 2021-09-01

Mutation profiling in gallbladder cancer in Indian population

by Niraj Kumari, Christopher L Corless, Andrea Warrick, Carol Beadling, Dylan Nelson, Tanay Neff, Narendra Krishnani, Vinay Kumar Kapoor
Published 2014-01-01

Loss of the PTCH1 tumor suppressor defines a new subset of plexiform fibromyxoma

by Sudeep Banerjee, Christopher L. Corless, Markku M. Miettinen, Sangkyu Noh, Rowan Ustoy, Jessica L. Davis, Chih-Min Tang, Mayra Yebra, Adam M. Burgoyne, Jason K. Sicklick
Published 2019-07-01

MDM2 Amplification and PI3KCA Mutation in a Case of Sclerosing Rhabdomyosarcoma

by Ken Kikuchi, George R. Wettach, Christopher W. Ryan, Arthur Hung, Jody E. Hooper, Carol Beadling, Andrea Warrick, Christopher L. Corless, Susan B. Olson, Charles Keller, Atiya Mansoor
Published 2013-01-01

Exome Sequencing of Cell-Free DNA from Metastatic Cancer Patients Identifies Clinically Actionable Mutations Distinct from Primary Disease.

by Timothy M Butler, Katherine Johnson-Camacho, Myron Peto, Nicholas J Wang, Tara A Macey, James E Korkola, Theresa M Koppie, Christopher L Corless, Joe W Gray, Paul T Spellman
Published 2015-01-01

Determination of stromal signatures in breast carcinoma.

by Robert B West, Dimitry S A Nuyten, Subbaya Subramanian, Torsten O Nielsen, Christopher L Corless, Brian P Rubin, Kelli Montgomery, Shirley Zhu, Rajiv Patel, Tina Hernandez-Boussard, John R Goldblum, Patrick O Brown, Marc van de Vijver, Matt van de Rijn
Published 2005-06-01

Implementing a comprehensive translational oncology platform: from molecular testing to actionability

by Zahi I. Mitri, Swapnil Parmar, Brett Johnson, Annette Kolodzie, Jamie M. Keck, Max Morris, Alexander R. Guimaraes, Brooke R. Beckett, Uma Borate, Charles D. Lopez, Kathleen A. Kemmer, Joshi J. Alumkal, Tomasz M. Beer, Christopher L. Corless, Gordon B. Mills, Joe W. Gray, Raymond C. Bergan
Published 2018-12-01

Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics

by Allen Li, Jamie M. Keck, Swapnil Parmar, Janice Patterson, Marilyne Labrie, Allison L. Creason, Brett E. Johnson, Molly Downey, George Thomas, Carol Beadling, Laura M. Heiser, Annette Kolodzie, Alexander R. Guimaraes, Christopher L. Corless, Joe W. Gray, Gordon B. Mills, Raymond C. Bergan, Zahi I. Mitri
Published 2021-03-01

MAX inactivation is an early event in GIST development that regulates p16 and cell proliferation

by Inga-Marie Schaefer, Yuexiang Wang, Cher-wei Liang, Nacef Bahri, Anna Quattrone, Leona Doyle, Adrian Mariño-Enríquez, Alexandra Lauria, Meijun Zhu, Maria Debiec-Rychter, Susanne Grunewald, Jaclyn F. Hechtman, Armelle Dufresne, Cristina R. Antonescu, Carol Beadling, Ewa T. Sicinska, Matt van de Rijn, George D. Demetri, Marc Ladanyi, Christopher L. Corless, Michael C. Heinrich, Chandrajit P. Raut, Sebastian Bauer, Jonathan A. Fletcher
Published 2017-03-01